Vericel Corp

NASDAQ:VCEL   3:59:54 PM EDT
30.14
-0.39 (-1.28%)
Products

Mediwound Announces U.S. FDA Acceptance Of Biologics License Application For Nexobrid For Treatment Of Severe Thermal Burns

Published: 08/03/2022 12:13 GMT
Vericel Corp (VCEL) - Mediwound Announces U.S. FDA Acceptance of Biologics License Application for Nexobrid for the Treatment of Severe Thermal Burns.
Mediwound Ltd - FDA Assigned a Prescription Drug User Fee Act (pdufa) Target Date of January 1, 2023.